Non-alcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Non-alcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-11Clinical Trial Update: Assessment of Fatty Liver With Thermo-acoustic Device
A clinical trial evaluating a thermo-acoustic device for fatty liver diseases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-03-15Clinical Trial Update: Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis [Phase 3]
Phase 3 clinical trial evaluating metadoxine for non-alcoholic steatohepatitis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-12Clinical Trial Update: Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis [Phase 3]
Phase 3 trial evaluating pentoxifylline with vitamin E versus vitamin E alone for non-alcoholic steatohepatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-25Clinical Trial Update: Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children
This clinical trial update notes the withdrawal of a study investigating a biomarker for pediatric non-alcoholic steatohepatitis.
-
CLINICAL_TRIALS withdrawal · 2012-08-28Clinical Trial Update: Natural Soybean-derived Femarelle ®for Patients With Non Alcoholic Fatty Liver Disease [Phase 4]
A Phase 4 trial of natural soybean-derived Femarelle for non-alcoholic fatty liver disease has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.